Definition of Lemtrada. Meaning of Lemtrada. Synonyms of Lemtrada

Here you will find one or more explanations in English for the word Lemtrada. Also in the bottom left of the page several parts of wikipedia pages related to the word Lemtrada and, of course, Lemtrada synonyms and on the right images related to the word Lemtrada.

Definition of Lemtrada

No result for Lemtrada. Showing similar results...

Meaning of Lemtrada from wikipedia

- Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis...
- Cerezyme Clolar Dupixent Elitek Eloctate Eloxatin Fabrazyme Jevtana Kevzara Lemtrada Libtayo Lumizyme Sarclisa Taxotare Zaltrap Genzyme has spent more than...
- Ofatumumab Subcutaneous 70% 0.09-0.14 Mavenclad Cladribine Oral 70% 0.1-0.14 Lemtrada Alemtuzumab Intravenous 70% 0.08 Ocrevus Ocrelizumab Intravenous 70% 0...
- name Zeposia Ponesimod (Ponvory) Five monoclonal antibodies: Alemtuzumab (Lemtrada, Campath). Natalizumab (Tysabri) Ocrelizumab (Ocrevus) which is also approved...
- epilepsy, now owned by AbbVie. Hyalgan (Sodium hyaluronate), for blood tests. Lemtrada (Alemtuzumab), for multiple sclerosis. Pediapred (Prednisolone), for multiple...
- conjugate HER2 Metastatic breast cancer 125427 Link alemtuzumab Campath, Lemtrada Genzyme 5/7/2001 intravenous humanized CD52 B-cell chronic lymphocytic...
- TNF-α sepsis Alacizumab pegol F(ab')2 humanized VEGFR2 cancer Alemtuzumab Lemtrada, Campath mab humanized CD52 Y multiple sclerosis Aliro****ab Praluent mab...
- of monoclonal antibodies anti-CD52 (Alemtuzumab, now approved by FDA as Lemtrada) for prevention of graft-vs-host disease (GVHD), the most serious complication...
- CD007621. doi:10.1002/14651858.CD007621.pub2. PMID 21975773. "FDA Approves Lemtrada". Biogen Idec Press Release. 14 November 2013. "FDA approves new drug to...
- their use to achieve tolerance, particularly Campath-1, now licensed as Lemtrada for the treatment of Multiple Sclerosis. Waldmann was elected a Fellow...